Abstract
Nonsteroidal anti-inflammatory drug (NSAID) indomethacin (indo) was loaded into cubic nanoporous silica SBA-16 modified by amine groups (A-SBA-16) or hematite SPIONs (Fe-SBA-16). The kinetic of the indomethacin release into physiological solution with pH = 7.4 was studied. After 72 h the released amount represented 91 % of the loaded amount for the unmodified SBA-16 and 63 % for the amine modified one. To study vectored drug delivery to the affected body organs with the assistance of magnetic field, SBA-16 was modified by Fe2O3 SPION nanoparticles and the magnetic properties of the sample were investigated by SQIUD magnetometry. The results show on superparamagnetic behaviour of the composite sample Fe-SBA-16 at room temperature with the value of effective magnetic moment m p ~ 384 μ B . It was shown that the superparamagnetic behaviour of Fe-SBA-16 did not change after the indomethacin incorporation. The kinetic of the drug release from the Fe-SBA-16/indo sample was similar to the SBA-16/indo sample in the first 50 h. However, the total released amount after the 72 h was for the Fe-SBA-16/indo sample lower (68 % of the loaded amount), indicating the stronger interaction of the drug with the porous carrier.
Similar content being viewed by others
References
J. Jyrkka, J. Mursu, H. Enlund, Polypharmacy and nutritional status in elderly people. Curr. Opin. Clin. Nutr. 15, 1–6 (2012)
M. Zhang, C.D.J. Holman, D.B. Preen, K.J. Brameld, Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980–2003. Br. J. Clin. Pharmacol. 63, 163–170 (2007)
S. Kwon, R.K. Singh, R.A. Perez, Silica-based mesoporous nanoparticles for controlled drug delivery. J. Tissue Eng. 4, 1–18 (2013)
J. Wong, A. Brugger, A. Khare, Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects. Adv. Drug Deliv. Rev. 60, 939–954 (2008)
R.A. Jain, The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials 21, 2475–2490 (2000)
Y.J. Kim, S. Choi, J.J. Koh, Controlled release of insulin from injectable biodegradable triblock copolymer. Pharm. Res. 18, 548–550 (2001)
R. Arshady, Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters. J. Control Release 17, 1–21 (1991)
F. Fenaroli, D. Westmoreland, J. Benjaminsen, Nanoparticles as drug delivery system against tuberculosis in zebrafish embryos: direct visualization and treatment. ACS Nano 8, 7014–7026 (2014)
R. Mo, T. Jiang, Z. Gu, Enhanced anticancer efficacy by ATP-mediated liposomal drug delivery. Angew. Chem. 126, 5925–5930 (2014)
A.M. Caminade, F.O. Turrina, Dendrimers for drug delivery. J. Mater. Chem. B. 2, 4055–4066 (2014)
I. Slowing, J. Vivero-Escoto, C.W. Wu, V.S. Lin, Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 60, 1278–1288 (2008)
Z. Li, J.C. Barnes, A. Bosoy, Mesoporous silica nanoparticles in biomedical applications. Chem. Soc. Rev. 41, 2590–2605 (2012)
F. Gao, P. Botella, A. Corma, Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA. J. Phys. Chem B. 113, 17961804 (2009)
M.V. Regí, A. Rámila, R.P. Real, J.P. Pariente, A new property of MCM-41: drug delivery system. Chem. Mater. 13, 308–311 (2001)
A. Rámila, B. Munoz, J.P. Pariente, M.V. Regí, Mesoporous MCM-41 as drug host system. J. Sol–Gel. Sci. Technol. 26, 1199–1202 (2003)
B. Munoz, A. Rámila, J.P. Pariente, I. Díaz, M.V. Regí, MCM-41 organic modification as drug delivery system. Chem. Mater. 15, 500–503 (2003)
P. Horcajada, A. Rámila, J.P. Pariente, M.V. Regí, Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater. 68, 105–109 (2004)
M. Manzano, V. Aina, C.O. Areán, F. Balas, V. Cauda, M. Collila, M.R. Delgado, M.V. Regí, Studies on MCM-41 mesoporous silica for drug delivery: effect of particle morphology and amine functionalization. J. Chem. Eng. 137, 30–37 (2008)
A.L. Doadrio, E.M.B. Sousa, J.C. Doadrio, J.P. Pariente, I. Barba, M.V. Regí, Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery. J. Control Release 97, 125–132 (2004)
J.C. Doadrio, E.M.B. Sousa, I.B. Isabel, A.L. Doadrio, J.P. Pariente, M.V. Regí, Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern. J. Mater. Chem. 16, 462–466 (2006)
C. Airoldi, V.V. Oliveira, Hydrophobic contribution to amoxicillin release associated with organofunctionalized mesoporous SBA-16 carriers. Mater. Res. Bull. 59, 214–222 (2014)
A. Kiwilsza, B. Milanowski, K. Druzbicki, L.E. Coy, M. Grzeszkowiak, M. Jarek, J. Mielcarek, J. Lulek, A. Pajzderska, J. Wasicki, Mesoporous drug carrier systems for enhanced delivery rate of poorly water-soluble drug: nimodipine. J. Porous Mater. 22, 817–829 (2015)
Q.Z. Zhai, Y.Y. Wu, X.H. Wang, Synthesis, characterization and sustaining controlled release effect of mesoporous SBA-15/ramipril composite drug. J. Incl. Phenom. Macrocycl. Chem. 77, 113–120 (2013)
J. Shen, G. Song, M. An, X. Li, N. Wu, K. Ruan, J. Hu, R. Hu, The use of hollow mesoporous silica nanospheres to encapsulate bortezomib and improve efficacy for non-small cell lung cancer therapy. Biomaterials 35, 316–326 (2014)
Z. Xu, Y. Ji, M. Guan, H. Huang, C. Zhao, H. Zhang, Preparation and characterization of l-leucine-modified amphiprotic bifunctional mesoporous SBA-15 molecular sieve as a drug carrier for ribavirin. Appl. Surf. Sci. 256, 3160–3165 (2010)
M. Moritz, Solvent optimization for niacinamide adsorption onorgano-functionalized SBA-15 mesoporous silica. Appl. Surf. Sci. 283, 537–545 (2013)
S. Sapino, E. Ugazio, L. Gastaldi, I. Miletto, G. Berlier, D. Zonari, S. Oliaro-Bosso, Mesoporous silica as topical nanocarriers for quercetin: characterization andin vitro studies. Eur. J. Pharm. Biopharm. 89, 116–125 (2015)
N. Gargiulo, A.M. Cusano, F. Causa, D. Caputo, P.A. Nett, Silver-containing mesoporous bioactive glass with improved antibacterial properties. J. Mater. Sci.: Mater.: Med. 24, 2129–2135 (2013)
V. Zeleňák, V. Hornebecq, P. Llewellyn, Zinc(II)-benzoato complexes immobilised in mesoporous silica host. Microporous Mesoporous Mater. 83, 125–135 (2005)
M. Moritz, M. Geszke-Moritz, Mesoporous silica materials with different structures as the carriersfor antimicrobial agent. Modelling of chlorhexidine adsorption and release. Appl. Surf. Sci. 356, 1327–1340 (2015)
S. Jangra, P. Girotra, V. Chhokar, V.K. Tomer, A.K. Sharma, S. Duhan, In-vitro drug release kinetics studies of mesoporous SBA-15 azathioprine composite. J. Porous Mater. (2016). doi:10.1007/s10934-016-0123-1
D. Halamová, M. Badaničová, V. Zeleňák, Naproxen drug delivery using periodic mesoporous silica SBA-15. Appl. Surf. Sci. 256, 6489–6494 (2010)
Y. Hu, J. Wang, Z. Zhi, T. Jiang, S. Wang, Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J. Colloid Interface Sci. 363, 410–417 (2011)
Y. Hu, Z. Zhi, Q. Zhao, C. Wu, P. Zhao, H. Jiang, T. Jiang, S. Wang, 3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol. Microporous Mesoporous Mater. 147, 94–101 (2012)
M.J.K. Thomas, I. Slipper, A. Walunj, A. Jain, M.E. Favretto, P. Kallinteri, D. Douroumis, Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int. J. Pharm. 387, 272–277 (2010)
S.A. Wahajuddin, Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int. J. Nanomed. 7, 3445–3471 (2012)
P. Yang, Z. Quan, Z. Hou, Ch. Li, X. Kang, Z. Cheng, J. Lin, A magnetic, luminiscent and mesoporous core-shell structured composite material as drug carrier. Biomaterials 30, 4786–4795 (2009)
S. Zhu, Z. Zhou, D. Zhang, C.H. Jin, Z. Li, Design and synthesis of delivery system based on SBA-15 with magnetic particles formed in situ and thermo-sensitive PNIPA as controlled switch. Microporous Mesoporous Mater. 106, 56–61 (2007)
S. Huang, C.H. Li, Z. Cheng, Y. Fan, P. Yang, C. Zhang, J. Lin, Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption. J. Colloids Interface Sci. 376, 312–321 (2012)
E.R. Hernández, A.L. Noriega, D. Arcos, M.V. Regí, Mesoporous magnetic microspheres for drug targeting. Solid State Sci. 10, 421–426 (2008)
K.C. Souza, J.D. Ardisson, E.M.B. Sousa, Study of mesoporous silica/magnetite systems in drug controlled release. J. Mater. Sci. Mater.: Med. 20, 507–512 (2009)
A.C. Moffat, J.V. Jackson, M.S.Moss, B.Widdop, in Isolation and Identification of Drugs (London, 1986)
T.W. Kim, R. Ryoo, M. Kruk, K.P. Gierszal, M. Jaroniec, S. Kamiya, O. Teresaki, Tailoring the pore structure of SBA-16 silica molecular sieve through the use of copolymer blends and control of synthesis temperature and time. J. Phys. Chem. B. 108, 11480–11489 (2004)
K.M.S. Khalil, H.A. Mahmoud, T.T. Ali, Direct formation of thermally stabilized amorphous mesoporous Fe2O3/SiO2 nanocomposites by hydrolysis of aqueous ion (III) nitrate in sols of spherical silica particles. Langmuir 24, 1037–1043 (2008)
D. Zhao, Q. Huo, J. Feng, B.F. Chmelka, G.D. Stucky, Nonionic triblock and star diblock copolymer and oligomeric surfactant synthesis of highly ordered, hydrothermally stable, mesoporous silica structures. J. Am. Chem. Soc. 120, 6024–6036 (1998)
Y. Sakamoto, M. Kaneda, O. Terasaki, D.Y. Zhao, J.M. Kim, G. Stucky, H.J. Shin, R. Ryoo, Direct imaging of the pores and cages of three-dimensional mesoporous materials. Nature 408, 449–453 (2000)
K.S.W. Sing, D.H. Everett, R.A.W. Haul, L. Moscou, R.A. Pierotti, J. Rouquerol, T. Siemieniewska, Reporting physisorption data for gas-solid systems with special reference to the determination of surface area and porosity. Pure Appl. Chem. 57, 603–619 (1985)
V. Zeleňák, A. Zeleňáková, J. Kováč, U. Vainio, N. Murafa, Influence of Surface Effects on Magnetic Behavior of Hematite Nanoparticles Embedded in Porous Silica Matrix. J. Phys. Chem. C 113, 13045–13050 (2009)
S. Bedanta, W. Wolfgang Kleemann, Supermagnetism. J. Phys. D Appl. Phys. 42, 013001 (2009)
M. Tadic, V. Kusigerski, D. Markovic, I. Milosevic, V. Spasojevic, High concentration of hematite nanoparticles in a silica matrix: structural and magnetic properties. J. Magn. Magn. Mater. 321, 12–16 (2009)
A. Figuerola, R. Di Corato, L. Manna, T. Pellegrino, From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharm. Res. 62, 126–143 (2010)
J. Salomen, L. Laitinen, A.M. Kaukonen, J. Tuura, M. Bjorkqvist, T. Heikkilä, K. Vähä-Heikkilä, J. Hirvonen, V.P. Lehto, Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control Release 108, 362–374 (2005)
J.M. Rosenholm, M. Lindén, Towards establishing structure—activity relationships for mesoporous silica in drug delivery applications. J. Control Release 128, 157–164 (2008)
Acknowledgments
This work was supported by the Slovak Research and Development Agency under the contract No. APVV-15-0520. V.Z. thanks Desy, Hasylab, Hamburg Germany for the support during synchrotron related measurements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zeleňák, V., Halamová, D., Zeleňáková, A. et al. Periodic 3D nanoporous silica modified by amine or SPION nanoparticles as NSAID delivery system. J Porous Mater 23, 1633–1645 (2016). https://doi.org/10.1007/s10934-016-0224-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10934-016-0224-x